Company Search:
Advanced Search
Sponsored Links
Provexis PLC Company Snapshot
Provexis PLC operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Provexis PLC with three other pharmaceutical manufacturers in Europe: Oasmia Pharmaceutical AB of SWEDEN (2019 sales of 1.98 million Swedish Kronor [US$222,175.80 ] of which 65% was Sales of goods), Kancera AB of SWEDEN (3.22 million Swedish Kronor [US$360,867.36 ] of which 100% was Operations), and Pharnext SA which is based in FRANCE (252,773.00 Euros [US$295,987.07 ] of which 100% was The conduct of research and development ).

Sales Analysis. During the year ended March of 2019, sales at Provexis PLC were £322,189.00 (US$410.43 thousand). This is an increase of 36.6% versus 2018, when the company's sales were £235,804.00 . This was the fifth consecutive year of sales increases at Provexis PLC (and since 2014, sales have increased a total of 8,022%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Provexis PLC
  Stock Performance Chart for Provexis PLC
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): .88p
(Figures in Pounds Sterling)
1 Week 0.0%   13 Weeks -5.4%  
4 Weeks 6.1%   52 Weeks 191.7%  
Provexis PLC Key Data:
  Ticker: PXS Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 322,189
(Year Ending Jan 2020).
Employees: 4
  Currency: Pounds Sterling Market Cap: 18,019,063
  Fiscal Yr Ends: March Shares Outstanding: 2,059,321,507
  Share Type: Ordinary Closely Held Shares: 367,113,462
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.